Subjective Response to Opioids Predicts Risk for Opioid Use Disorder
Gonzalez, J.; Tran, V.; Meredith, J.; Xu, I.; Penchala, R.; Vilar Ribo, L.; Courchesne-Krak, N. S.; Zoleikhaeian, D.; 23andMe Research Team, ; McIntyre, M.; Fontanillas, P.; Kukar Bond, K.; Johnson, E. O.; Jeffery, A.; MacKillop, J.; Marienfeld, C.; de Wit, H.; Palmer, A. A.; Sanchez-Roige, S.
Show abstract
BackgroundOpioid use disorder (OUD) is a major public health crisis. Patients initial exposure to opioids often comes from prescribed medications. Predicting which of these patients will develop OUD remains challenging. Prior evidence from various substances suggest that initial subjective responses influence addiction risk, however these studies have used relatively small cohorts and have not led to the development of widespread tools to predict OUD risk. MethodsWe used a cohort of 141,897 adult research participants to perform a retrospective observational study of self-reported subjective responses to prescription opioids. We collected demographics, subjective positive (e.g., euphoria), subjective negative (e.g., nausea), and analgesic responses as well as self-reported OUD. ResultsPositive subjective effects, particularly "Like Overall", "Euphoric", and "Energized", were the strongest predictors of OUD. For example, the odds-ratio for individuals responding "Extremely" for "Like Overall" was 36.5. The sensitivity and specificity of this single question was excellent (ROC=0.87). Negative effects and analgesic effects were much less predictive. We developed a two-question decision tree ("When you first took opioid pain medication, to what extent did you like the way they made you feel overall?" and "When you first took opioid pain medication, to what extent did you experience an unpleasant itchy feeling?"), that can identify a small high-risk subset with 78.5% prevalence of OUD and a much larger low-risk subset with 1.2% prevalence of OUD. ConclusionsScreening for subjective responses can identify high-risk individuals who would benefit from tailored interventions.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Medication Improves Age Disparities in Six-Month Treatment Retention for Opioid Use Disorder 93%
- Changes in injecting versus smoking heroin, fentanyl, and methamphetamine among people who inject drugs in San Diego, California, 2020 to 2023 92%
- Fentanyl, Heroin, and Methamphetamine-Based Counterfeit Pills Sold at Tourist-Oriented Pharmacies in Mexico: An Ethnographic and Drug Checking Study 92%
Similar papers in this journal
- Ibrutinib as a Potential Therapeutic for Cocaine Use Disorder 93%
- Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases. 93%
- Association between Functional Inhibitors of Acid Sphingomyelinase and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: results from an observational multicenter study 92%
Similar papers in this journal
- Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals 93%
- Bipolar disorder and cannabis use: a bidirectional two-sample Mendelian randomization study 91%
- Effects of acute and repeated administration of the selective M4 PAM VU0152099 on cocaine vs. food choice in male rats 91%
Similar papers in this journal
- Association of Topiramate Prescribed for any Indication with Reduced Alcohol Consumption in Electronic Health Record Data 94%
- WITHDRAWN: Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients 92%
- Association of opioid use disorder with healthcare utilization and cost in a public health system 92%
Similar papers in this journal
- Association of cannabis use-related predictor variables and self-reported psychotic disorders: US adults, 2001-2002 and 2012-2013 91%
- Stratifying Risk for Postpartum Depression at Time of Hospital Discharge 90%
- Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.